What the December directive said
In December 2025, President Donald Trump directed the Attorney General to complete the rulemaking process concerning moving marijuana to Schedule III, in accordance with federal law. The directive itself was not a completed rescheduling rule.
That distinction matters. A political instruction, a regulatory process, and the public’s understanding of a substance are related, but they are different things. This article is a reflection on the cultural signal sent at that moment.
White House — December 2025 directive on marijuana and cannabidiol research
Policy can change the way a substance is perceived
In the original piece, I argued that the cultural effect could matter as much as the policy itself. A change in official language may influence whether people think of cannabis as prohibited, medical, ordinary, or harmless. That is an interpretation of the moment, not a measured outcome of the directive.
Reform can be discussed seriously while still taking people’s difficulties with cannabis seriously. Recognizing potential medical uses does not mean that every product, pattern of use, or personal experience is equivalent.
Keep the health question separate
Cannabis use can become difficult to control. The CDC describes cannabis use disorder as including continued use despite problems in health or daily life. A policy announcement does not answer whether someone’s own pattern of use is working for them.
The useful personal questions remain concrete: Is this interfering with plans? Am I using more often than I intended? Do I want help making a change? Those questions deserve attention regardless of the wider political debate.
Why it belongs in the Kurb conversation
At Kurb, our interest is in the relationship between access and everyday behavior. How do people make a plan when something is easy to reach for? What kind of practical boundary would fit into their lives?
Kurb gives that question a physical form through scheduled access. It does not settle the cannabis policy debate, establish a safe dose, or treat dependence.
My view remains that reform and realistic expectations can coexist. A less stigmatizing conversation should also leave room for people who want more structure, want to cut back, or need professional support.